Global Senior Medical Director, Gastroenterology, non-MD

ROLE SUMMARY

• Reporting to the VP, Global Gastroenterology Medical Lead, the Senior Director, Gastroenterology (GI) and Biosimilars is an integral member of the Specialty Care GI Global Medical team. The GI and Biosimilaers Senior Medical Director will serve as an expert in the GI area and the Pfizer biosimilars portfolio (including Abrilada, Ixifi and Inflectra) while also providing strategic input to the Etrasimod and Tofacitinib medical strategy and plan to ensure Pfizers leadership, consistency and alignment across GI assets.
• He/She will be a core member of the GI GMAT and will work closely with the Global Medical Gastroenterology lead to develop the GI scientific narrative and the strategic GI medical plan across assets
• The Global Senior Director , GI and Biosimilars will work collaboratively across the broader medical team and cross-functional business partners (e.g. Global marketing, Global health economics and outcomes research colleagues, Regional and Country medical teams, Global Clinical Development, Medical information, Regulatory, Safety, etc.) to develop and execute an effective Biosimilars Global Medical Affairs plan, supporting launches across (IXIFI, ABRILADA and Inflectra) as well as regulatory activities
• In conjunction with team members, the incumbent will also develop long-term relationships with a wide variety of key healthcare stakeholders and external customers to include medical groups and key opinion leaders to demonstrate the clinical value of the Pfizer Biosimilars portfolio in the treatment of IBD and potentially other inflammatory conditions.
• The Global Senior Medical Director , GI and Biosimilars will also provide Pfizer brand teams with customer and clinical insights to assist in informing Pfizer strategies on critical health issues and facilitate the development of customer-focused tools and medical communications to support patient access to quality medicines.

ROLE RESPONSIBILITIES

• Collaborate with regional and country medical teams to understand major unmet medical needs, including access challenges to biologics, and medical environment including HCP, payers, and patient perspective, regulatory and access dynamics at the country level and integrate needs and insights to co-create a global medical strategic and operating plan for the biosimilars portfolio and ensuring strategic alignment across assets.
• Cross functional efforts with constituents from global commercial and marketing, regional and country medical, PHI and HEOR, and other cross-functional colleagues to drive Global strategic direction for the biosimilars portfolio as well as for the broader GI portfolio.
• Support several launches across the biosimilars (IXIFY, ABRILADA and Inflectra).
• Demonstrate deep data and disease area expertise for gastroenterology and rheumatology.
• Demonstrate deep understanding of biosimilar development and science of biosimilarity.
• Understand Global treatment guidelines, regulations and policy on the use and access to biologics in chronic inflammatory conditions.
• Lead evidence dissemination and education activities including scientific publications and scientific exchange on matters of biosimilarity as well as on above brand IBD state.
• Conduct ongoing assessment of the benefit-risk of the biosimilars portfolio taking into account new data, as they become available.
• Chairs global advisory board meeting with external experts on relevant asset read out/new data/issues
• Serve as a reliable, trusted source of accurate scientific knowledge for clinical data, disease state, product label and competitive data sets in the field of GI with a special focus on inflammatory bowel disease
• Serve as medical SMEs for promotional material review
• Lead the strategy and development of a comprehensive data generation plan including independent research, clinical and research collaborations, and Pfizer non-interventional and interventional studies and post-hoc data generation based on the data gaps analysis
• Support internal medical training curriculum in collaboration with the Medical Academy and Content development group
• Be a champion for new operating model and ensure simplicity and clarity at every opportunity while maintaining Pfizer compliance standards.
• Support a high functioning and performance culture for team

BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• PharmD/PhD
• Board certification or extensive Inflammation experience preferred
• Demonstrated experience with biosimilars
• Cross functional effectiveness
• Ability to be seen as a subject matter expert on matters related to the complex and highly evolving biosimilars market by key stakeholders such as regulators, advocacy groups, governments, and payers
• A minimum of eight years industry experience required
• Experience in Medical Affairs required
• International experience required
• Research experience and scientific acumen is required
• Team-oriented and action-oriented for success with ability to act with a sense of urgency when appropriate
• Well-organized with the ability to be flexible, prioritize multiple demands, and effectively lead in a matrix organization
• Proven track record of ability to work successfully with cross-functional colleagues in a matrix team setting across countries and internationally with diverse colleagues
• Very strong communications and relationship building capacity and ability to listen, understand and integrate different country and regional needs into the global plan
• Ability to prioritize, make tradeoff decisions, and do the critical few well; ability to promote accelerated decision making and operational delivery, while maintaining Pfizer standards.
• Regulatory and/or clinical development experience a plus
• Fluency in written and spoken English required

PREFERRED QUALIFICATIONS

• Academic research experience is preferred
• Launch experience preferred
• Clinical trial experience a plus
• Above-country experience preferred and international experience a plus
• Regulatory and/or clinical development experience a plus
• Proven ability to facilitate open discussion and debate among key stakeholders and build internal and external relationships

Last Day to Apply: May 24, 2024
The annual base salary for this position ranges from $191,300.00 to $318,800.00. In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 22.5% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site - U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Medical
#LI-PFE